These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22752616)

  • 21. [QTc-prolonging drugs and the risk of sudden death].
    Reingardiene D; Vilcinskaite J
    Medicina (Kaunas); 2007; 43(4):347-53. PubMed ID: 17485963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ECG Diagnosis: Ibutilide-induced Torsade de Pointes.
    Le DD; Levis JT; Lugovskaya N; Vinson DR
    Perm J; 2019; 23():. PubMed ID: 30939273
    [No Abstract]   [Full Text] [Related]  

  • 23. Torsades de pointes associated with chlorpromazine: case report and review of associated ventricular arrhythmias.
    Hoehns JD; Stanford RH; Geraets DR; Skelly KS; Lee HC; Gaul BL
    Pharmacotherapy; 2001 Jul; 21(7):871-83. PubMed ID: 11444585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QT Interval prolongation and torsades de pointes due to a coadministration of ciprofloxacin and azimilide in a patient with implantable cardioverter-defibrillator.
    Kaźmierczak J; Peregud-Pogorzelska M; Rzeuski R
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):1043-6. PubMed ID: 17669094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular drugs inducing QT prolongation: facts and evidence.
    Taira CA; Opezzo JA; Mayer MA; Höcht C
    Curr Drug Saf; 2010 Jan; 5(1):65-72. PubMed ID: 20210721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-induced proarrhythmia and use of QTc-prolonging agents: clues for clinicians.
    Heist EK; Ruskin JN
    Heart Rhythm; 2005 Nov; 2(2 Suppl):S1-8. PubMed ID: 16253926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sotalol-induced torsades de pointes in patients with renal failure.
    Dancey D; Wulffhart Z; McEwan P
    Can J Cardiol; 1997 Jan; 13(1):55-8. PubMed ID: 9039065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sotalol-induced torsades de pointes precipitated during treatment with oseltamivir for H1N1 influenza.
    Wells Q; Hardin B; Raj SR; Darbar D
    Heart Rhythm; 2010 Oct; 7(10):1454-7. PubMed ID: 20656063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs that cause Torsades de pointes and increase the risk of sudden cardiac death.
    Wolbrette DL
    Curr Cardiol Rep; 2004 Sep; 6(5):379-84. PubMed ID: 15306095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiologic parameters and predisposing factors in the generation of drug-induced Torsade de Pointes arrhythmias.
    Vos MA; van Opstal JM; Leunissen JD; Verduyn SC
    Pharmacol Ther; 2001; 92(2-3):109-22. PubMed ID: 11916532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired long QT syndromes and the risk of proarrhythmia.
    Roden DM
    J Cardiovasc Electrophysiol; 2000 Aug; 11(8):938-40. PubMed ID: 10969760
    [No Abstract]   [Full Text] [Related]  

  • 32. Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.
    Nair MK; Patel K; Starer PJ
    Addiction; 2008 Dec; 103(12):2062-4. PubMed ID: 19469750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced QT prolongation and sudden death.
    Del Rosario ME; Weachter R; Flaker GC
    Mo Med; 2010; 107(1):53-8. PubMed ID: 20222297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An in vitro model for assessment of drug-induced torsade de pointes arrhythmia : effects of haloperidol and dofetilide on potential duration, repolarization inhomogeneities, and torsade de pointes arrhythmia.
    Dhein S; Perlitz F; Mohr FW
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):631-44. PubMed ID: 18648775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced prolongation of the QT interval: why the regulatory concern?
    Shah RR
    Fundam Clin Pharmacol; 2002 Apr; 16(2):119-24. PubMed ID: 12031064
    [No Abstract]   [Full Text] [Related]  

  • 36. Torsades de Pointes: a rare complication of an extra-adrenal pheochromocytoma.
    Methe H; Hinterseer M; Wilbert-Lampen U; Beckmann BM; Steinbeck G; Kääb S
    Hypertens Res; 2007 Dec; 30(12):1263-6. PubMed ID: 18344633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation.
    Yap YG; Camm J
    BMJ; 2000 Apr; 320(7243):1158-9. PubMed ID: 10784527
    [No Abstract]   [Full Text] [Related]  

  • 38. Sotalol unmasks susceptibility to drug-induced long QT syndrome and torsades de pointes.
    Letsas KP; Efremidis M; Sideris A
    Int J Cardiol; 2008 Mar; 124(3):366-7; author reply 368-9. PubMed ID: 17400314
    [No Abstract]   [Full Text] [Related]  

  • 39. Moxifloxacin-induced torsades de pointes.
    Sherazi S; DiSalle M; Daubert JP; Shah AH
    Cardiol J; 2008; 15(1):71-3. PubMed ID: 18651388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes.
    Schwartz PJ; Woosley RL
    J Am Coll Cardiol; 2016 Apr; 67(13):1639-1650. PubMed ID: 27150690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.